Parameters | Platelet counts (× 103/ mm3) | P | ||
---|---|---|---|---|
< 400 (n = 227) | ≥ 400 (n = 53) | |||
Age (years) | Mean ± SD | 56.8 ± 11.9 | 55.9 ± 11.9 | 0.52 |
Hb (g/ dl) | Mean ± SD | 12.1 ± 1.4 | 10.9 ± 1.7 | < 0.0001 |
Microcytic hypochromic anemia | 0.00090 | |||
Present | 12 (5.3%) | 11 (20.8%) | ||
Absent | 215 (94.7%) | 42 (79.2%) | ||
Primary treatment | 0.0028 | |||
PDS | 177 (78.0%) | 30 (56.6%) | ||
NAC | 50 (22.0%) | 23 (43.4%) | ||
FIGO stage | 0.0018 | |||
I | 82 (36.1%) | 9 (17.0%) | ||
II | 35 (15.4%) | 4 (7.5%) | ||
III | 84 (37.0%) | 26 (49.1%) | ||
IV | 26 (11.5%) | 14 (26.4%) | ||
Histologic subtype | 0.034 | |||
Serous | 77 (33.9%) | 28 (52.8%) | ||
Clear cell | 70 (30.8%) | 13 (24.5%) | ||
Others* | 80 (35.3%) | 12 (22.7%) | ||
Operation achievement | 0.00050 | |||
Complete | 178 (78.4%) | 28 (52.8%) | ||
Optimal | 36 (15.9%) | 20 (37.7%) | ||
Suboptimal | 13 (5.7%) | 5 (9.5%) | ||
Nonmalignant inflammatory condition | 0.0022 | |||
Present | 7 (3.1%) | 8 (15.1%) | ||
Absent | 220 (96.9%) | 45 (84.9%) | ||
CA125 (U/ mL) | Mean ± SD | 1233 ± 3012 | 3127 ± 5278 | < 0.0001 |